Retrovirus from the HIV type O and its use (MVP-2901/94)

Details Retrovirus from the HIV type O and its use (MVP-2901/94) Retrovirus from the HIV type O and its use (MVP-2901/94)

2005-12-13

2005-12-13

Stucker, Jeffrey (Department: 1648)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S024300, C536S024320, C536S024330, C435S006120, C435S235100, C435S974000

Reexamination Certificate

active

06974866

ABSTRACT:
A novel HIV type O immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European collection of animal Cell Cultures (ECACC) under No. V 950121601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.

REFERENCES:
patent: 5840480 (1998-11-01), Guertler et al.
Riffkin et al. A single amino-acid change between the antigenically different extracellular serine protease V2 and B2 fromDichelobacter nodous. Gene (1995) vol. 167, pp. 279-283.
Ngo et al, in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Edited by Merz et al., (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.

Affiliated with

Also associated with

Rating

Retrovirus from the HIV type O and its use (MVP-2901/94) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retrovirus from the HIV type O and its use (MVP-2901/94), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retrovirus from the HIV type O and its use (MVP-2901/94) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3489743